MK 0873: Clinical Trials

2 trials of MK 0873, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Terminated 1

Follow MK 0873: new trials by email Literature Review of MK 0873 trials Research Report on MK 0873

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of a Novel Investigational Drug in Rheumatoid Arthritis Patients (MK-0873-012)(COMPLETED)
MK-0873, Comparator: Placebo - Rheumatoid Arthritis
Phase 2CompletedMerck Sharp & Dohme LLC1062005-01-012015-07-30
An Investigational Drug Study In Patients With COPD (Chronic Obstructive Pulmonary Disease) (MK-0873-005)
MK-0873 2.5 mg, MK-0873 1.25 mg, MK-0873 0.75 mg - Lung Diseases, Pulmonary Disease, Chronic Obstructive
Phase 2TerminatedMerck Sharp & Dohme LLC6042004-06-012018-10-12

Conditions studied

Arthritis, Rheumatoid (1)  ·  Lung Diseases (1)  ·  Pulmonary Disease, Chronic Obstructive (1)

Sponsors

Merck Sharp & Dohme LLC (2)